Shenping Liu
Impact in
- Molecular Biology top 10%
- Biochemical and Molecular Research
- Chemical Synthesis and Analysis
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 4
- Phosphodiesterase function and regulation 4
- Receptor Mechanisms and Signaling 3
- Oncology 9
- Peptidase Inhibition and Analysis 4
- Co-authors
- Jon ClardyRichard A. CerioneChristopher W. KempCraig M. CrewsJoanne WidomTrudy H. GrossmanXiayang QiuJohn D. Knafels
- Journals
- Journal of Biological Chemistry (7 papers)Nature Communications (4 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Shenping Liu
37 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.2k
- Oncology 439
- Organic Chemistry 351
- Pharmaceutical Science 70
- Cancer Research 169
Countries citing papers authored by Shenping Liu
This map shows the geographic impact of Shenping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenping Liu more than expected).
Fields of papers citing papers by Shenping Liu
This network shows the impact of papers produced by Shenping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenping Liu. The network helps show where Shenping Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shenping Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 14 | |
| 5 | 2019 | 13 | |
| 6 | 2018 | 25 | |
| 7 | 2017 | 48 | |
| 8 | 2015 | 41 | |
| 9 | 2012 | 61 | |
| 10 | 2012 | 56 | |
| 11 | 2012 | 10 | |
| 12 | 2011 | 16 | |
| 13 | 2009 | 33 | |
| 14 | 2007 | 13 | |
| 15 | 2006 | 139 | |
| 16 | 2002 | 268 | |
| 17 | 2000 | 268 | |
| 18 | 1998 | 4 | |
| 19 | 1994 | 43 | |
| 20 | 1993 | 51 |
About Shenping Liu
Shenping Liu is a scholar working on Molecular Biology, Oncology, Genetics, Biochemistry and Cellular and Molecular Neuroscience, having authored 39 papers that have together received 2.1k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Neuropeptides and Animal Physiology (4 papers), Protein Degradation and Inhibitors (4 papers), Phosphodiesterase function and regulation (4 papers), Erythrocyte Function and Pathophysiology (3 papers), Multiple Myeloma Research and Treatments (3 papers), Diabetes Treatment and Management (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Oncology (439 citations), Organic Chemistry (351 citations), Pharmaceutical Science (70 citations) and Cancer Research (169 citations). Shenping Liu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Jon Clardy, Richard A. Cerione, Christopher W. Kemp, Craig M. Crews, Joanne Widom, Trudy H. Grossman, Xiayang Qiu, John D. Knafels, Jeanne S. Chang and Xi Song. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.